MSACL 2024Monterey, CA : March 17-22 |
|
The Booth and Poster Tours program is designed to facilitate meaningful interactions among attendees in small groups, fostering the exchange of intellect and experiences. This initiative holds particular value for first-time MSACL attendees, providing them with the chance to connect with colleagues who share similar interests. Additionally, it serves as a valuable opportunity for early-career attendees to approach, interact, and build connections with mid- to late-career professionals within the community.
Booth and Poster Tours: Guides browse booths or view posters as they normally would, but with one or more participants along to observe, join discussions and learn from the experience.
You can sign up at the conference to participate in Guided Activities (i.e., Booth Tour, Poster Tour).
Tuesday | 20:00 - 21:00 | Booth Tours Exhibit Hall - Serra (Conference Ctr > Ground Floor) |
Wednesday | 14:30 - 15:45 | Poster Session 2 with Poster Tours Exhibit Hall - Serra (Conference Ctr > Ground Floor) |
Thursday | 9:15 - 10:30 | Poster Session 3 with Poster Tours Exhibit Hall - Serra (Conference Ctr > Ground Floor) |
Jessica Colón-Franco, PhD |
Poster Tour 3 on Thursday @ 9:15
|
||
Dr Jessica M Colón-Franco is Section Head of Clinical Biochemistry and Director of the Special Chemistry Laboratory at Cleveland Clinic, and adjunct faculty at Cleveland State University in Cleveland, OH. In her current role, Jessica provides strategic, clinical and scientific direction to the clinical laboratories in the section. Previously, Jessica was Director of Chemistry, Toxicology and Point-of-Care at Wisconsin Diagnostic Laboratories and Associate Professor at the Medical College of Wisconsin in Milwaukee, WI. Jessica obtained her bachelor’s degree in industrial biotechnology from the University of Puerto Rico at Mayagüez, Puerto Rico and her doctorate degree in Biochemistry and Molecular Biology from the Mayo Graduate School, College of Medicine in Rochester, MN. She completed a fellowship in Clinical Chemistry at Vanderbilt University Medical Center in Nashville, TN. Jessica is a diplomate of the American Board of Clinical Chemistry, fellow of the AACC Academy and is a member of several laboratory medicine associations, where she has served in various committee roles. Jessica’s interests are focused on endocrinology, therapeutic drug monitoring and toxicology, and inflammatory biomarkers. | |||
Robert Fitzgerald, PhD, DABCC |
Poster Tour 2 on Wednesday @ 14:30 Poster Tour 3 on Thursday @ 9:15
|
||
Robert L. Fitzgerald, PhD, DABCC Dr. Fitzgerald received his BS degree in Chemistry at Loyola College of Maryland, and his PhD in Pharmacology/Toxicology at the Medical College of Virginia/Virginia Commonwealth University. After two and a half years as a forensic toxicologist for the State of Virginia, he took a position as the Director of the Mass Spectrometry Laboratory at the San Diego VA Hospital. Currently, Dr. Fitzgerald is a Professor in the Department of Pathology at the University of California, San Diego where he is the director of the toxicology laboratory and associate director of the clinical chemistry laboratory. He is board certified in toxicology and clinical chemistry by the American Board of Clinical Chemistry. He is the director of the clinical chemistry fellowship at UCSD. | |||
Elizabeth Frank, PhD |
Booth Tour on Tuesday @ 20:00 Poster Tour 2 on Wednesday @ 14:30 Poster Judge on March 2-10 (PDF Review) & 20-21 (Interview Finalists) @ Time TBD
|
||
Elizabeth L. Frank, PhD, is a professor of pathology at the University of Utah School of Medicine and a medical director at ARUP Laboratories, a national reference laboratory operated by the University of Utah, in Salt Lake City. She is certified as a clinical chemist by the American Board of Clinical Chemistry and is a fellow of the AACC Academy. Dr. Frank's clinical and scientific interests are focused on measurement of biogenic amines, porphyrins, and vitamins using HPLC and LC-MS/MS; determination of calculi composition using FTIR; biochemical assessment of nephrolithiasis risk; and use of laboratory test results to evaluate health status. | |||
Joshua Hayden, PhD, DABCC, FACB |
Booth Tour on Tuesday @ 20:00 Poster Tour 3 on Thursday @ 9:15 Poster Judge on March 2-10 (PDF Review) & 20-21 (Interview Finalists) @ Time TBD
|
||
Joshua is currently the Chief of Chemistry at NortonHealthcare. He earned his PhD in chemistry from Carnegie Mellon University. He conducted postdoctoral research at Massachusetts Institute of Technology before completing a two-year clinical chemistry fellowship at University of Washington and 4 years as Assistant Professor at Weill Medical College. Joshua has special expertise developing and overseeing mass spectrometry assays in the clinical laboratory. | |||
David Herold, MD, PhD |
Booth Tour on Tuesday @ 20:00
|
||
David Herold received his BS (1966) in Chemistry from Tulane University. He completed his MA (1972) in Chemistry at the University of North Carolina-Chapel Hill, served 5 years in the USAF, received his MD (1979) and PhD (1982) at the University of Utah and then completed a Clinical Pathology residency (1982) at the University of Virginia. In 1982 he joined the University of Virginia faculty. In 1991 he moved to the University of California, San Diego and is now Professor of Pathology. He has authored and co-authored over 80 scientific publications and presented at numerous international scientific conferences. Inspired by the 2007 ASMS Asilomar conference on clinical mass spectrometry, Dr. Herold co-founded MSACL. From 2008 to the present, he has served as CEO, Executive Board Chair and Global Scientific Coordinator of MSACL. MSACL's mission is to further the accumulation and sharing of expertise in mass spectrometry and other advanced technologies in the clinical laboratory through educational advancement. MSACL will continue building the foundation for the adoption of technology in the clinical laboratory, including data science, based on the belief that this will provide more accurate, precise and timely laboratory results at lower overall costs that will result in better patient care and outcomes. | |||
Claire Knezevic, PhD |
Booth Tour on Tuesday @ 20:00 Poster Judge on March 2-10 (PDF Review) & 20-21 (Interview Finalists) @ Time TBD
|
||
Dr. Claire Knezevic is a clinical chemist in the Department of Pathology and Laboratory Medicine at Lurie Children's Hospital with a focus on chemistry, point-of-care testing, quality improvement, drug monitoring, and personalized medicine. She is an Associate Professor in Northwestern's Feinberg School of Medicine in the Department of Pathology. Her interests include all things small molecule, from toxicology to therapeutic drug monitoring and their impacts on clinical care. | |||
Guinevere Lageveen-Kammeijer, PhD |
Poster Tour 2 on Wednesday @ 14:30 Poster Judge on March 2-10 (PDF Review) & 20-21 (Interview Finalists) @ Time TBD
|
||
Guinevere received her PhD on exploring prostate-specific antigen (PSA), the well-known biomarker for prostate cancer, and its glycosylation by capillary electrophoresis and mass spectrometry. Since 2022, Guinevere is appointed as an Assistant Professor (tenure track) in the Analytical Biochemistry group at the Univeristy of Groningen She currently works on further expanding a mass spectrometry-based PSA glycosylation assay which she developed during her PhD. In addition, she explores the possibilities for the in-depth analysis of glycans and intact glycoproteins for biomarker discovery for other diseases as well as for the characterization of biopharmaceuticals. In 2017, Guinevere joined the organization committee of the Netherlands Area Biotech (NLab) Discussion group of CASSS. In 2019, she became a member of the scientific committee of the glycomics session, and a member of the early career committee, of MSACL EU. Her research interests are focused on bringing together researchers from the field of biomarker discovery with clinical laboratory professionals, ensuring a better translation of potential biomarkers to the clinic. Moreover, she is dedicated to convincing her fellow colleagues that glycosylation is an important subject and should not be neglected just because it is rather complicated. | |||
Gwen McMillin, PhD |
Poster Tour 3 on Thursday @ 9:15
|
||
Dr. McMillin is a Professor (Clinical) at the University of Utah in the Department of Pathology and a Medical Director for Clinical Toxicology, Mass Spectrometry and Pharmacogenomics at ARUP Laboratories. She received her Ph.D. in Pharmacology and postdoctoral training in clinical chemistry from the University of Utah. Dr. McMillin is board certified by the American Board of Clinical Chemistry in Clinical Chemistry and Toxicological Chemistry. She also currently serves as a member of the Executive Board for the ARUP Institute of Clinical and Experimental Pathology and is actively involved in several external Professional Organizations. | |||
Alejandro Molinelli, PhD |
Poster Tour 3 on Thursday @ 9:15
|
||
Alejandro Molinelli, PhD is Director of the Clinical Pharmacokinetics Laboratory in the Department of Pharmacy and Pharmaceutical Sciences at St. Jude Children's Research Hospital. His duties include clinical consultancy, technical and regulatory oversight of the laboratory, and method development and validation. Dr. Molinelli also serves as a Clinical Chemist Consultant with the Department of Pathology at St. Jude. Prior to joining St. Jude Dr. Molinelli completed a Clinical Chemistry Fellowship at the University of Washington in Seattle; obtained his PhD in toxicology at the University of North Carolina at Chapel Hill; and bachelor’s and master’s degrees in biology and biochemistry at the University of Puerto Rico. Dr. Molinelli’s professional interests include therapeutic drug monitoring, clinical toxicology, and quality improvement. | |||
Laura Sanchez, PhD |
Booth Tour on Tuesday @ 20:00 Poster Tour 2 on Wednesday @ 14:30 Poster Tour 3 on Thursday @ 9:15 Poster Judge on March 2-10 (PDF Review) & 20-21 (Interview Finalists) @ Time TBD
|
||
Laura started her independent lab in the Fall of 2015 at the University of Illinois at Chicago in the Department of Pharmaceutical sciences. The lab relocated to the University of California, Santa Cruz Department of Chemistry and Biochemistry in January 2021. Her team specializes in using and adapting imaging mass spectrometry and tandem mass spectrometry for small molecule analyses in complex systems. Laura was a K12 BIRCWH Scholar (2016-2017) which supported the translation of the techniques to women's health. She was the Rising Star in the Life Sciences in 2019 at UIC. | |||
Raymond Suhandynata, PhD DABCC |
Booth Tour on Tuesday @ 20:00 Poster Tour 2 on Wednesday @ 14:30
|
||
Dr. Suhandynata is an Assistant Professor at the University of California San Diego with appointments in the Skaggs School of Pharmacy and Department of Pathology. He serves as the Associate Laboratory Director for the CMCR reference laboratory and the Associate Director of the UCSD ComACC clinical chemistry fellowship. He completed his Clinical Chemistry fellowship training at the UC San Diego Center for Advanced Laboratory Medicine, under the direction of Dr. Robert Fitzgerald. He has extensive experience with applications of mass spectrometry in research, pre-clinical, and clinical laboratories. Areas of interest include phospho-proteomics to identify novel kinase targets by LC-MS/MS, SUMO proteomics to identify cellular signals involved in chromosome segregation, utilization of MALDI-TOF MS in to identify antibiotic resistant bacteria in the clinical specimens, and development of targeted LC-MRM/PRM assays for small molecules and peptides. Addtionally, he as made significant contributions during the COVID-19 pandemic, validating several COVID-19 serology LDTs at UCSD Health. |